Dihydro-CP Interactions
There are 708 drugs known to interact with Dihydro-CP (chlorpheniramine / dihydrocodeine / pseudoephedrine), along with 26 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 136 are major, 564 are moderate, and 8 are minor.
- View all 708 medications that may interact with Dihydro-CP
- View Dihydro-CP alcohol/food interactions (1)
- View Dihydro-CP disease interactions (26)
Most frequently checked interactions
View interaction reports for Dihydro-CP (chlorpheniramine / dihydrocodeine / pseudoephedrine) and the medicines listed below.
- Aleve (naproxen)
- amitriptyline
- amoxicillin
- Ativan (lorazepam)
- Bayer Aspirin with Heart Advantage (aspirin)
- captopril
- codeine
- diazepam
- diclofenac
- dihydrocodeine / guaifenesin
- gabapentin
- Mucinex (guaifenesin)
- naproxen
- omeprazole
- Paracetamol (acetaminophen)
- Paxil (paroxetine)
- pravastatin
- prednisone
- pregabalin
- ropinirole
- Tylenol (acetaminophen)
Dihydro-CP alcohol/food interactions
There is 1 alcohol/food interaction with Dihydro-CP (chlorpheniramine / dihydrocodeine / pseudoephedrine).
Dihydro-CP disease interactions
There are 26 disease interactions with Dihydro-CP (chlorpheniramine / dihydrocodeine / pseudoephedrine) which include:
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- cardiovascular disease
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
- GI narrowing
- PKU
- BPH
- diabetes
- glaucoma
Report options
More about Dihydro-CP (chlorpheniramine / dihydrocodeine / pseudoephedrine)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.